Researchers in the cancer nanomedicine community debate whether use of tiny structures, called nanoparticles, can best deliver drug therapy to tumors passively -- allowing the nanoparticles to diffuse into tumors and become held in place, or actively -- adding a targeted anti-cancer molecule to bind to specific cancer cell receptors and, in theory, keep the nanoparticle in the tumor longer. Now, new research on human and mouse tumors in mice suggests the question is even more complicated.
from Top Technology News -- ScienceDaily https://ift.tt/2JdzWi2
Thursday, 26 March 2020
Experiments in mice and human cells shed light on best way to deliver nanoparticle therapy for cancer
Posted By: Unknown - March 26, 2020About Unknown
Magazine Power Theme is officially developed by Templatezy Team. We published High quality Blogger Templates with Awesome Design for blogspot lovers.The very first Blogger Templates Company where you will find Responsive Design Templates.
Subscribe to:
Post Comments (Atom)
SOCIALIZE IT →